Package 63323-315-94

Brand: ganciclovir

Generic: ganciclovir sodium
NDC Package

Package Facts

Identity

Package NDC 63323-315-94
Digits Only 6332331594
Product NDC 63323-315
Description

25 VIAL in 1 TRAY (63323-315-94) / 10 mL in 1 VIAL (63323-315-41)

Marketing

Marketing Status
Marketed Since 2010-06-28
Brand ganciclovir
Generic ganciclovir sodium
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "e51e0b68-6b11-42f5-82a2-87c480cb5c41", "openfda": {"upc": ["0363323315412"], "unii": ["02L083W284"], "rxcui": ["310442"], "spl_set_id": ["35addab5-09db-4f8a-9c69-6fbce33ecc37"], "manufacturer_name": ["Fresenius Kabi USA, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "25 VIAL in 1 TRAY (63323-315-94)  / 10 mL in 1 VIAL (63323-315-41)", "package_ndc": "63323-315-94", "marketing_start_date": "20100628"}], "brand_name": "Ganciclovir", "product_id": "63323-315_e51e0b68-6b11-42f5-82a2-87c480cb5c41", "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION", "pharm_class": ["Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "DNA Polymerase Inhibitors [MoA]", "Nucleoside Analog Antiviral [EPC]", "Nucleoside Analog [EXT]"], "product_ndc": "63323-315", "generic_name": "GANCICLOVIR SODIUM", "labeler_name": "Fresenius Kabi USA, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Ganciclovir", "active_ingredients": [{"name": "GANCICLOVIR SODIUM", "strength": "500 mg/10mL"}], "application_number": "ANDA090658", "marketing_category": "ANDA", "marketing_start_date": "20100628", "listing_expiration_date": "20271231"}